REDDY-DASATINIB
Identification of Reddy-Dasatinib
| No description |
Google image searchProduct monograph
Active ingredient
dasatinib (dasatinib (s)-propylene glycol), 50 MG
DIN: 02514745
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: DR REDDY'S LABORATORIES LTD
Date: 16-SEP-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EA — BCR-ABL tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EA02 — DASATINIB (ATC/DDD)
Reference brand drug: Sprycel
Pharmaceutical standard: MFR
